Study of LEE011plus Cetuximab in Patients With a Cancer of the Head and Neck

Condition:   Squamous Cell Carcinoma of the Head and Neck
Intervention:   Drug: LEE011
Sponsor:   Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Recruiting - verified April 2016

from #ORL via xlomafota13 on Inoreader http://ift.tt/1Th1gdd
via IFTTT